Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 765	$ 19,639
Accounts receivable	16	61
Inventory	6	278
Prepaid expenses, deposits, and other current assets	1,343	4,520
Total current assets	2,130	24,498
Fixed assets, net	216	1,783
Operating lease right-of-use assets	2,618	4,267
Intangible assets, net		1,424
Equity method investment - at fair value	25,511
Other assets	75	1,147
Total assets	30,550	33,119
Current liabilities:
Accounts payable	465	1,786
Accrued expenses and other current liabilities	4,543	6,626
Operating lease liabilities, current portion	499	1,565
Senior Secured Convertible Notes - at fair value	32,050	44,200
Total current liabilities	37,557	54,177
Operating lease liabilities, less current portion	2,380	2,960
Total liabilities	39,937	57,137
Commitments and contingencies (Note 9)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,385,149 at September 30, 2024 and 1,305,213 shares at December 31, 2023	3,232	2,993
Common stock, $0.001 par value. Authorized, 50,000,000 shares; 10,660,394 and 8,578,505 shares outstanding as of September 30, 2024 and December 31, 2023, respectively	11	9
Additional paid-in capital	248,200	237,600
Accumulated deficit	(256,312)	(294,433)
Total PAVmed Inc. Stockholders’ Equity (Deficit)	(4,869)	(53,831)
Noncontrolling interests	(4,518)	29,813
Total Stockholders’ Equity (Deficit)	(9,387)	(24,018)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 30,550	$ 33,119